Management of neovascular age-related macular degeneration: Taiwan expert consensus-Reference-Cited by-同舟云学术

Management of neovascular age-related macular degeneration: Taiwan expert consensus

Published:2021-12 Issue:12 Volume:120 Page:2061-2071
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Yeung Ling,Hsieh Yi-Ting,Yang Chang-Hao,Chen Lee-Jen,Chen Shih-Jen^ORCID,Cheng Cheng-Kuo,Sheu Shwu-Jiuan,Tsai Ching-Yao,Wu Tsung-Tien,Wu Wei-Chi,Chen San-Ni^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference68 articles.

1. Risk factors for age-related macular degeneration: pooled findings from three continents;Smith;Ophthalmology,2001

2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014

3. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis;Kawasaki;Ophthalmology,2010

4. Prevalence of age-related macular degeneration in Chinese populations worldwide: a systematic review and meta-analysis;Jin;Clin Exp Ophthalmol,2019

5. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study;Chen;Invest Ophthalmol Vis Sci,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinal and choroidal changes after anti-VEGF therapy in neovascular-AMD patients: A systematic review and meta-analysis of SD-OCT studies;Survey of Ophthalmology;2024-07

2. Reduction of retinal vessel density in non-exudative macular neovascularization: a retrospective study;Frontiers in Medicine;2024-01-04

3. Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis;BMC Ophthalmology;2023-11-21

4. Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study;Clinical Ophthalmology;2023-08

5. Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis;BMC Ophthalmology;2023-01-27